Safety and tolerability of MEDI3506 in healthy participants, in participants with COPD and healthy Japanese participants

Trial Identifier:	D9180C00001
Sponsor:	MedImmune, LLC
NCTID::	NCT03096795
Start Date:	May 2017
Primary Completion Date:	September 2019
Study Completion Date:	September 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom, HA1 3UJ
United Kingdom	Manchester, United Kingdom, M23 9QZ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.